TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27166238

Group type: EXPERIMENTAL
Intervention: JZP-110 150 mg/day weeks 1-4 and 300 mg/day weeks 5-12
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 25708712

Group type: EXPERIMENTAL
Intervention: Water-based training (3 days/week for 12 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 23715565

Group type: EXPERIMENTAL
Intervention: Obese men (BMI ≥ 30 kg/m²)
Number of subjects: 1931

Group type: COMPARATOR
Intervention: Normal-weight men (BMI 18.5 to 24.9 kg/m²)
Number of subjects: 1931

Group type: EXPERIMENTAL
Intervention: Women (all BMI categories)
Number of subjects: 1931
Study: 21265309

Group type: EXPERIMENTAL
Intervention: 60-minute dental trauma lecture
Number of subjects: 336

Group type: COMPARATOR
Intervention: Control group (structured questionnaire)
Number of subjects: 336
Study: 19057854

Group type: EXPERIMENTAL
Intervention: rhu EPO, 500u per kg, per week, 2 times weekly, subcutaneous
Number of subjects: 40
Study: 16176313

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with mivacurium (0.2 mg.kg(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol anesthesia with mivacurium (0.2 mg.kg(‐1))
Number of subjects: 60
Study: 12952091

Group type: EXPERIMENTAL
Intervention: New discriminant combining parameters from a non-Rayleigh statistic model of backscattered envelope.
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Combined parameters with level of suspicion (LOS) scores of a radiologist.
Number of subjects: 99
Study: 10489111

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 9063758

Group type: EXPERIMENTAL
Intervention: Policosanol 5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Policosanol 10 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Policosanol 20 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Policosanol 25 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Policosanol 50 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 1845806

Group type: EXPERIMENTAL
Intervention: Oral Polio Vaccine (OPV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced-Potency Inactivated Polio Vaccine (E-IPV)
Number of subjects: 0
Study: 6338689

Group type: EXPERIMENTAL
Intervention: Digoxin 0.25 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Digoxin 0.375 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 13
Study: 30394672

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation (ARP) with a d‐PTFE membrane and freeze‐dried irradiated allogenic bone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Natural socket healing (control)
Number of subjects: 34
Study: 29367425

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/d
Number of subjects: 7863

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7863
Study: 26901301

Group type: EXPERIMENTAL
Intervention: VISTA technique using Bio‐Gide membrane enhanced with GEM 21S
Number of subjects: 15

Group type: COMPARATOR
Intervention: Periosteal pedicle graft (PPG)
Number of subjects: 15
Study: 24492159

Group type: EXPERIMENTAL
Intervention: Novel patient counseling program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study: 22947589

Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU weekly for 8 weeks
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 20566398

Group type: EXPERIMENTAL
Intervention: Test Food First (TFF)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Test Food Last (TFL)
Number of subjects: 57
Study: 17662632

Group type: EXPERIMENTAL
Intervention: Homocysteine (Hcy)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Weight
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Hemoglobin
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Uric acid
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Blood glucose
Number of subjects: 184
Study: 15124669

Group type: EXPERIMENTAL
Intervention: High-dose AraC during induction therapy
Number of subjects: 938

Group type: COMPARATOR
Intervention: Standard-dose AraC during induction therapy
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: G-CSF priming
Number of subjects: 938

Group type: COMPARATOR
Intervention: No G-CSF priming
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation
Number of subjects: 938

Group type: COMPARATOR
Intervention: Maintenance therapy
Number of subjects: 938
Study: 11236040

Group type: EXPERIMENTAL
Intervention: NebuChamber
Number of subjects: 141

Group type: COMPARATOR
Intervention: Babyhaler
Number of subjects: 141
Study: 9714355

Group type: EXPERIMENTAL
Intervention: TH and rifampicin (TH+R)
Number of subjects: 82

Group type: COMPARATOR
Intervention: TH alone
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TH and methotrexate (TH+M)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TH+R
Number of subjects: 82
Study: 7913644

Group type: EXPERIMENTAL
Intervention: Metipranolol (3 mg/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine (2.5 mg/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine (2.5 mg/ml) and Metipranolol (3 mg/ml)
Number of subjects: 40
Study: 2726319

Group type: EXPERIMENTAL
Intervention: Protein-enriched groups
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-protein-enriched groups
Number of subjects: 28
Study: 1177789

Group type: EXPERIMENTAL
Intervention: ISDN retard (slow-release isosorbide dinitrate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 31545048

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fast food diet (FF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HDL-associated proteins including ApoE
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HDL functional capacity
Number of subjects: 10
Study: 29037635

Group type: EXPERIMENTAL
Intervention: Talocrural joint manipulation (TCJM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 40
Study: 25991421

Group type: EXPERIMENTAL
Intervention: Pre-storage filtration (group 1, n=53)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Bedside filtration (group 2, n=53)
Number of subjects: 106
Study: 23269401

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (VyproII(®), TiMesh(®))
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard polypropylene (Marlex(®))
Number of subjects: 59
Study: 23200592

Group type: EXPERIMENTAL
Intervention: Lung volume reduction coil treatment (LVRC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 100
Study: 19188101

Group type: EXPERIMENTAL
Intervention: BodyThink program (4 sessions of 50 minutes each)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (usual classes)
Number of subjects: 277
Study: 17425783

Group type: EXPERIMENTAL
Intervention: Abatacept (750 mg infusion)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (vaccines on day 1 only)
Number of subjects: 80
Study: 15383785

Group type: EXPERIMENTAL
Intervention: Mesh repair
Number of subjects: 181

Group type: COMPARATOR
Intervention: Suture repair
Number of subjects: 181
Study: 11242721

Group type: EXPERIMENTAL
Intervention: Enhanced feedback intervention (EFI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Written feedback intervention (WFI)
Number of subjects: 29
Study: 9500570

Group type: EXPERIMENTAL
Intervention: acute hyperglycemic hyperinsulinemia (HG) with plasma glucose at 15 mmol/L
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: euglycemic hyperinsulinemia (HI) with plasma insulin at 80 mU/L and glucose at 4 to 5 mmol/L
Number of subjects: 6

Group type: COMPARATOR
Intervention: intravenous (i.v.) saline (control)
Number of subjects: 6
Study: 7884300

Group type: EXPERIMENTAL
Intervention: PREP (both global and bridging)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Global or bridging part of PREP
Number of subjects: 51
Study: 1697950

Group type: COMPARATOR
Intervention: Absent rate response (VVI in the Sensolog group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyporesponsive (DDD in the dual chamber group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Appropriate response (VVIR, DDDR according to Manufacturer's instructions)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Over responsive (VVIR+, DDDR+)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study: 343509

Group type: EXPERIMENTAL
Intervention: Theophylline ethylenediamine, 400 mg orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide, 5 mg orally
Number of subjects: 0
Study: 31315940

Group type: EXPERIMENTAL
Intervention: HIIT+MICT
Number of subjects: 82

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 82
Study: 30740955

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 801

Group type: COMPARATOR
Intervention: Laparotomy (LT)
Number of subjects: 801
Study: 28828489

Group type: EXPERIMENTAL
Intervention: MVC
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: MVC-FTC
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: MVC-TDF
Number of subjects: 188

Group type: COMPARATOR
Intervention: TDF-FTC
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 188
Study: 25759235

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (CR) intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Wait list (WL) control condition
Number of subjects: 48
Study: 24582466

Group type: EXPERIMENTAL
Intervention: Convergence exercises
Number of subjects: 156

Group type: COMPARATOR
Intervention: Encouraged control group
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Accommodation exercises
Number of subjects: 156

Group type: COMPARATOR
Intervention: Other treatment groups
Number of subjects: 156
Study: 22430457

Group type: EXPERIMENTAL
Intervention: Shifts in BMI category (e.g., overweight to healthy weight)
Number of subjects: 3993

Group type: EXPERIMENTAL
Intervention: Shifts in BMI category (e.g., healthy weight to overweight)
Number of subjects: 3993

Group type: EXPERIMENTAL
Intervention: Increases in BMI category
Number of subjects: 3993

Group type: EXPERIMENTAL
Intervention: Decreases in BMI category
Number of subjects: 3993

Group type: EXPERIMENTAL
Intervention: Boys who increased BMI category
Number of subjects: 3993
Study: 19915236

Group type: EXPERIMENTAL
Intervention: Therapeutic circumcision
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (uncircumcised males)
Number of subjects: 20
Study: 17690923

Group type: EXPERIMENTAL
Intervention: P-teeth group (periosteum contacting the tooth surface)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: P-flap group (periosteum contacting the flap)
Number of subjects: 8
Study: 15101293

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 2226

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2226
Study: 11712773

Group type: EXPERIMENTAL
Intervention: INVEST (treatment for 12 months)
Number of subjects: 81649
Study: 9613267

Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.125 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.25 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.375 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 80
Study: 7815243

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (10-12 mg/kg/day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid with taurine (18-22 mg/kg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 51
Study: 1662233

Group type: EXPERIMENTAL
Intervention: 250 mg/kg IVIG (Gammagard)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 500 mg/kg IVIG (Gammagard)
Number of subjects: 31
Study: 373921

Group type: EXPERIMENTAL
Intervention: Domperidone 2 mg/ml injected IV 1 hour before cytostatic treatment and again 4 hours later
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo injected IV 1 hour before cytostatic treatment and again 4 hours later
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Domperidone 2 mg/ml
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31319102

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sleep deprivation intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Nonintervention control
Number of subjects: 81
Study: 28490230

Group type: EXPERIMENTAL
Intervention: In utero hematopoietic cell transplantation (IUHCT)
Number of subjects: 79
Study: 26032934

Group type: EXPERIMENTAL
Intervention: Chemical peeling combined with physical effect (4% AHA solution)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Chemical peeling alone (control group)
Number of subjects: 23
Study: 24144073

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 1079
Study: 22277458

Group type: EXPERIMENTAL
Intervention: High-dose dabigatran
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose dabigatran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabigatran (both doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabigatran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 18687056

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 20
Study: 16891861

Group type: EXPERIMENTAL
Intervention: peptides + Montanide ISA‐51
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: peptides + Montanide ISA‐51 + GM‐CSF (10 microg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: peptides + Montanide ISA‐51 + GM‐CSF (50 microg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 25
Study: 16988082

Group type: EXPERIMENTAL
Intervention: Family-based intervention (2000 additional steps/day and 2 servings/day of ready-to-eat cereal for 13 weeks)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control condition (no specific intervention details provided)
Number of subjects: 105
Study: 14698782

Group type: EXPERIMENTAL
Intervention: [(11)C]‐meta‐hydroxyephedrine for pre-synaptic function
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: [(11)C]‐CGP12177 for post-synaptic function
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Pre-synaptic function
Number of subjects: 28
Study: 10569322

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: ambulatory ischemia monitoring
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: exercise testing
Number of subjects: 686

Group type: COMPARATOR
Intervention: treatment effects on ambulatory ischemia
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: ventricular premature complexes
Number of subjects: 686
Study: 8912401

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 107

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 107
Study: 1860640

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 21

Group type: COMPARATOR
Intervention: No operation (Control)
Number of subjects: 21
Study: 6349651

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (300 mg per day for 6 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenylbutazone (500 mg per day for 1 week and 300 mg per day for 5 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg per day for 6 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29444627

Group type: EXPERIMENTAL
Intervention: Boys who perpetrated sexual IPV
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Boys' attitudes toward perpetrating sexual IPV
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Boys' perception of social network influence
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Boys' self-efficacy to refrain from pressuring
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Perpetrators vs. nonperpetrators
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Intention not to perpetrate sexual IPV
Number of subjects: 2199
Study: 31943761

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - antenatal/postnatal intervention with proactive telephone support and written materials
Number of subjects: 400

Group type: COMPARATOR
Intervention: Active Control Group (ACG) - received active control intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard Care Group (SCG) - received standard care
Number of subjects: 400
Study: 29388845

Group type: EXPERIMENTAL
Intervention: Optive Advanced
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Optive
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 28602417

Group type: EXPERIMENTAL
Intervention: Short-course radiation therapy (25 Gy in 5 fractions, arm 1)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Commonly used radiation therapy (40 Gy in 15 fractions, arm 2)
Number of subjects: 61
Study: 26261149

Group type: EXPERIMENTAL
Intervention: Removal of dental materials in patients with oral lichenoid lesions (13 patients consented to removal)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Patch tests for dental restoration materials
Number of subjects: 45
Study: 24024324

Group type: EXPERIMENTAL
Intervention: Decoction for reinforcing lung Qi and argon helium lancet
Number of subjects: 76

Group type: COMPARATOR
Intervention: Argon helium lancet only (Control)
Number of subjects: 76
Study: 21373180

Group type: EXPERIMENTAL
Intervention: Cocaine-cues video
Number of subjects: 26

Group type: COMPARATOR
Intervention: Neutral video (nature scenes)
Number of subjects: 26
Study: 17828390

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 40,000 IU
Number of subjects: 2

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 2
Study: 16317311

Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg/day)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 14962907

Group type: EXPERIMENTAL
Intervention: Maternal antithrombotic prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11054013

Group type: EXPERIMENTAL
Intervention: Topical furosemide after surgical treatment
Number of subjects: 104

Group type: COMPARATOR
Intervention: No treatment after surgical treatment (Control)
Number of subjects: 104
Study: 9296823

Group type: EXPERIMENTAL
Intervention: Electrocauthery plus immunotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Local electrocauthery over turbinate processes alone
Number of subjects: 40
Study: 8437304

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 286
Study: 3614615

Group type: COMPARATOR
Intervention: 10 mg diazepam
Number of subjects: 12
Study: 29054485

Group type: EXPERIMENTAL
Intervention: Polygenic risk scores (PRS) at p-threshold of 1e-07
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: Polygenic burden
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: PRS
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: Set-based analyses
Number of subjects: 730
Study: 26703894

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (100% oxygen at 2.4 ATA)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham control (21% oxygen at 1.3 ATA)
Number of subjects: 84
Study: 24919694

Group type: EXPERIMENTAL
Intervention: Photo of an overweight model
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Photo of a morbidly obese model
Number of subjects: 563

Group type: COMPARATOR
Intervention: No photo
Number of subjects: 563
Study: 22456820

Group type: EXPERIMENTAL
Intervention: Intensive ultrasound imaging (5 scans throughout pregnancy)
Number of subjects: 2834

Group type: COMPARATOR
Intervention: Regular ultrasound imaging (1 scan at 18 weeks)
Number of subjects: 2834
Study: 20860506

Group type: EXPERIMENTAL
Intervention: Enhanced-support group (telephone intervention)
Number of subjects: 174120

Group type: COMPARATOR
Intervention: Usual-support group (no enhanced intervention)
Number of subjects: 174120
Study: 18754819

Group type: EXPERIMENTAL
Intervention: Pause-and-perfect training method
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional observation method
Number of subjects: 28
Study: 15627731

Group type: EXPERIMENTAL
Intervention: Ultrasound elasticity imaging in ESRD subjects
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ultrasound elasticity imaging in healthy controls
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ultrasound elasticity imaging in transplant renal cortical strain for subject with CAN
Number of subjects: 12
Study: 12576316

Group type: EXPERIMENTAL
Intervention: R-CHOP (rituximab plus CHOP)
Number of subjects: 399

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 399
Study: 10642731

Group type: EXPERIMENTAL
Intervention: Navigated diffusion-weighted images and ADC maps with voxel-based parameter sets of relaxation times (T1, T2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T1 relaxation incorporated into the data set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T2- or diffusion-weighted images combined with ADC maps
Number of subjects: 0
Study: 8878069

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (0.25‐0.5 U/kg/week)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 15
Study: 1959783

Group type: EXPERIMENTAL
Intervention: Weekly cisplatin in combination with epirubicin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Weekly cisplatin in combination with etoposide
Number of subjects: 40
Study: 6318351

Group type: EXPERIMENTAL
Intervention: Bi‐Profenid 150 mg (two daily doses of 150 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Indomethacin (two daily doses of 50 mg)
Number of subjects: 20